Individual risk prediction of nodal and distant metastasis for patients with typical bronchial carcinoid tumors

European Journal of Cardio-thoracic Surgery

Volumn 34, Issue 3, 2008, Pages 473-478

  Das Neves Pereira, Joao Carlos ^a,b,c   Bagan, Patrick ^d   Milanez de Campos, Jose Ribas ^a   Capelozzi, Vera Luiza ^a   Danel, Claire ^b   Jatene, Fabio Biscegli ^a   Bernaudin, Jean François ^c   Riquet, Marc ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c HÔPITAL TENON   (France)

^d CENTRE HOSPITALIER VICTOR DUPOUY   (France)

Author keywords

Angiogenesis; Carcinoid tumors; Logistic regression; Metastasis; Neuroendocrine carcinoma; Prediction

Indexed keywords

COLLAGEN FIBER; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; BRONCHUS CARCINOID; CANCER LOCALIZATION; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CANCER SIZE; CANCER STAGING; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATIENT ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCREENING TEST; UNIVARIATE ANALYSIS; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRONCHIAL NEOPLASMS; CARCINOID TUMOR; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INFANT; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SEX FACTORS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 49149097555     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.06.008     Document Type: Article

References (25)

1. Beasley M., Brambilla E., and Travis W. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol 40 2 (2005) 90-97
2. Francioni F., Rendina E.A., Venuta F., Pescarmona E., De Giacomo T., and Ricci C. Low grade neuroendocrine tumors of the lung (bronchial carcinoids)-25 years experience. Eur J Cardiothorac Surg 4 9 (1990) 472-476
3. Kamiyoshihara M., Hirai T., Kawashima O., Ishikawa S., Morishita Y., and Maeshima A. Low-grade malignant tumors of the lung: is lymph node dissection necessary?. Oncol Rep 5 4 (1998) 841-843
4. García-Yuste M., Molins L., Matilla J., González-Aragoneses F., López-Pujol J., Ramos G., de la Torre M., Members of the Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pulmonology, and Thoracic Surgery (EMETNE-SEPAR). Trends in prognostic factors for neuroendocrine lung tumors. Arch Bronconeumol 43 10 (2007) 549-556
5. Pelosi G., Scarpa A., Puppa G., Veronesi G., Spaggiari L., Pasini F., Maisonneuve P., Iannucci A., Arrigoni G., and Viale G. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Cancer 103 6 (2005) 1154-1164
6. Pelosi G., Pasini F., Fraggetta F., Pastorino U., Iannucci A., Maisonneuve P., Arrigoni G., De Manzoni G., Bresaola E., and Viale G. Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids. Lung Cancer 42 2 (2003) 203-213
7. Das-Neves-Pereira J.C., da Silva A.G., Soares F., Ab'Saber A.M., Schmidt A., Rodrigues O.R., Garippo A., Capelozzi M., Milanez-de-Campos J.R., Takagaki T., Jatene F.B., Martins S., and Capelozzi V.L. Nuclear and environment morphometric profile in tumor size and nodal metastasis of resected typical pulmonary carcinoid. Pathol Res Pract 200 6 (2004) 459-467
8. Trufelli D., Matos L., Das-Neves-Pereira J.C., Santos A., Sander J., Capelozzi V., and Souto R. Bcl 2 family proteins and lymph node metastasis in bronchopulmonary carcinoid tumors. Eur J Cancer 3 S341 (2005) 89
9. Matos L., Das-Neves-Pereira J.C., Trufelli D., Stabenow E., Fernezlian S., Silva I., Milanez-de-Campos J.R., Jatene F., Capelozzi V., and Pinhal M. Heparanase expression in lung carcinoid tumors by immunohistochemistry. Eur J Cancer 3 S342 (2005) 89
10. Rzepecki W. Carcinoid of the bronchus as a cause of lung destruction and complete bronchial obstruction during surgery. Gruzlica 33 9 (1965) 821-822
11. Barbareschi M., Girlando S., Mauri F.A., Arrigoni G., Laurino L., Dalla Palma P., and Doglioni C. Tumour suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms. J Pathol 166 4 (1992) 343-350
12. Hasleton P.S., and al-Saffar N. The histological spectrum of bronchial carcinoid tumours. Appl Pathol 7 4 (1989) 205-218
13. Warren W.H., Gould V.E., Faber L.P., Kittle C.F., and Memoli V.A. Neuroendocrine neoplasms of the bronchopulmonary tract. A classification of the spectrum of carcinoid to small-cell carcinoma and intervening variants. J Thorac Cardiovasc Surg 89 6 (1985) 819-825
14. Stabenow E., Tavares M.R., Ab'Saber A.M., Parra-Cuentas E.R., de Matos L.L., Eher E.M., Capelozzi V.L., and Ferraz A.R. Angiogenesis as an indicator of metastatic potential in papillary thyroid carcinoma. Clinics 60 3 (2005) 233-240
15. Slodkowska J., Sikora J., Androsiuk W., Rudzinski P., and Radomyski A. Lung carcinoids. Tumor angiogenesis in relation to clinicopathologic characteristics. Anal Quant Cytol Histol 21 3 (1999) 267-272
16. Das-Neves-Pereira J.C., de Matos L.L., Danel C., Trufelli D., and Riquet M. Typical bronchopulmonary carcinoid tumors: a ramifying bronchial presentation with metastatic behavior. Ann Thorac Surg 82 6 (2006) 2265-2266
17. Daddi N., Ferolla P., Urbani M., Semeraro A., Avenia N., Ribacchi R., Puma F., and Daddi G. Surgical treatment of neuroendocrine tumors of the lung. Eur J Cardiothorac Surg 26 4 (2004) 813-817
18. Belhocine T., Foidart J., Rigo P., Najjar F., Thiry A., Quatresooz P., and Hustinx R. Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67. Nucl Med Commun 23 8 (2002) 727-734
19. Oberg K., and Eriksson B. Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours. Best Pract Res Clin Endocrinol Metab 19 2 (2005) 265-276
20. Maggiore C., Mule A., Fadda G., Rossi E.D., Lauriola L., Vecchio F.M., and Capelli A. Histological classification of lung cancer. Rays 29 4 (2004) 353-355
21. Warren W.H., Memoli V.A., and Gould V.E. Immunohistochemical and ultrastructural analysis of bronchopulmonary neuroendocrine neoplasms. II. Well-differentiated neuroendocrine carcinomas. Ultrastruct Pathol 7 2-3 (1984) 185-199
22. Savjak D., and Medenica M. Correlation between the clinical and pathohistologic diagnosis in "small biopsies" of the lung. Med Pregl 51 9-10 (1998) 431-435
23. Marmor S., Koren R., Halpern M., Herbert M., and Rath-Wolfson L. Transthoracic needle biopsy in the diagnosis of large-cell neuroendocrine carcinoma of the lung. Diagn Cytopathol 33 4 (2005) 238-243
24. Morero J.A., Dronda S.B., and Valles E.C. Bronchial carcinoid tumor: diagnosis by fiberoptic bronchoscopy. Arch Bronconeumol 37 3 (2001) 150-152
25. Stridsberg M., Eriksson B., Fellstrom B., Kristiansson G., and Tiensuu Janson E. Measurements of chromogranin B can serve as a complement to chromogranin A. Regul Pept 139 1-3 (2007) 80-83